In addition, the cumulative proportion of patients who achieved the target Hb concentration at Week 7 was higher in the FC-high group than the FC-low group, suggesting that FC at 1000 mg/day has a stronger effect in the improvement of anemia than FC at 500 mg/day. The gene discussed is GSTM1; the disease is anemia.